• Product NameBezafibrate
• Brief DescriptionInhibitors
• Purification99.00%
• Biological ActivityBezafibrate(BM15075) is the first clinically tested dual and pan-PPAR co-agonism.
• Target NamePPAR agonist
• CAS No. 41859-67-0
• Calculated MW 361.82
• Formulation C19H20ClNO4
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Metabolism system
  SMILES:CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O
  Pathways:Metabolism
  Receptor:PPARα
  Boling pt:572.1C?
  Melting pt:184C
  Solubility:Ethanol: 18 mg/mL (49.74 mM); DMSO: 72 mg/mL (198.99 mM)
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Tenenbaum A, et al. Cardiovasc Diabetol. 2005 Sep 16;4:14.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting